Skip to contentCOLES N ANTHONY — Ceres, Inc. insider: 283 transactions · InsiderLensCOLES N ANTHONY
- Director at NPS PHARMACEUTICALS INC · on record since Jan 19, 2006
- Director at ONYX PHARMACEUTICALS INC · on record since Apr 2, 2008
- Director at Campus Crest Communities, Inc. · on record since Oct 19, 2010
- Director at LABORATORY CORP OF AMERICA HOLDINGS · on record since Jan 5, 2011
- SVP, Comm. Ops. at VERTEX PHARMACEUTICALS INC / MA · on record since Dec 15, 2003
- Director at CRISPR Therapeutics AG · on record since Oct 26, 2016
- Chairman & CEO at ONYX PHARMACEUTICALS INC · on record since Jun 7, 2013
- Director at MCKESSON CORP · on record since May 16, 2014
- Director at REGENERON PHARMACEUTICALS INC · on record since Jan 31, 2017
- Director at Ceres, Inc. · on record since Oct 30, 2020
- Director at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Dec 28, 2020
- Executive Chair at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Dec 28, 2020
- CEO and Chairperson at Ceres, Inc. · on record since Oct 30, 2020
- President, COO & Director at NPS PHARMACEUTICALS INC · on record since Nov 7, 2005
Insider trading activity of COLES N ANTHONY
- Transactions on record
- 283
- since Dec 15, 2003
- Open-market buys
- 0
- Open-market sells
- 87
- $78.8M
- Companies traded
- 10
- last filing Jan 6, 2026
Figures computed from official regulatory filings — methodology.
Companies where COLES N ANTHONY has traded
- REGENERON PHARMACEUTICALS INC71 tx · $32.5M · Jan 6, 2026
- Ceres, Inc.84 tx · $33.6M · Aug 5, 2024
- PERFORMANCE TECHNOLOGIES INC \DE\7 tx · Apr 2, 2021
- MCKESSON CORP10 tx · $558.3K · Aug 19, 2020
- CRISPR Therapeutics AG4 tx · $980K · Jun 2, 2017
- ONYX PHARMACEUTICALS INC66 tx · $56.2M · Oct 3, 2013
- Campus Crest Communities, Inc.4 tx · May 31, 2013
- LABORATORY CORP OF AMERICA HOLDINGS6 tx · Feb 19, 2013
- NPS PHARMACEUTICALS INC22 tx · $302K · Mar 18, 2008
Track record of COLES N ANTHONY
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of COLES N ANTHONY
Co-insiders of COLES N ANTHONY
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
9 tx · Jul 22, 2005
Alfieri MichaelPERFORMANCE TECHNOLOGIES INC \DE\
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 6, 2026 | Award | 155 | 0.00 USD | $0 | SEC |
| Jan 6, 2026 | AwardD | 1,962 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | AwardD | 1,958 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | Award | 166 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | OtherD | -46,322 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | Other | -10,290 | — | — | SEC |
| Aug 5, 2024 | Other | -15,638 | — | — | SEC |
| Aug 5, 2024 | OtherD | -4,809,418 | — | — | SEC |
| Jul 3, 2024 | Exercise | 25,000 | 3.50 USD | $87.5K | SEC |
| Jul 3, 2024 | ExerciseD | -25,000 | 0.00 USD | $0 | SEC |
| Jul 3, 2024 | Sell | -25,000 | 41.18 USD | $1M | SEC |
| Jun 7, 2024 | Award | 10,290 | — | — | SEC |
| Jun 5, 2024 | Sell | -50,000 | 40.61 USD | $2M | SEC |
| Jun 5, 2024 | Exercise | 50,000 | 3.50 USD | $175K | SEC |
| Jun 5, 2024 | ExerciseD | -50,000 | 0.00 USD | $0 | SEC |
| May 14, 2024 | Exercise | 50,000 | 3.50 USD | $175K | SEC |
| May 14, 2024 | Sell | -50,000 | 42.10 USD | $2.1M | SEC |
| May 14, 2024 | ExerciseD | -50,000 | 0.00 USD | $0 | SEC |
| Apr 3, 2024 | Exercise | 50,000 | 3.50 USD | $175K | SEC |
| Apr 3, 2024 | ExerciseD | -50,000 | 0.00 USD | $0 | SEC |
| Apr 3, 2024 | Sell | -50,000 | 42.33 USD | $2.1M | SEC |
| Mar 6, 2024 | ExerciseD | -50,000 | 0.00 USD | $0 | SEC |
| Mar 6, 2024 | Exercise | 50,000 | 3.50 USD | $175K | SEC |
| Mar 6, 2024 | Sell | -50,000 | 41.01 USD | $2.1M | SEC |
| Mar 4, 2024 | Sell | -50,000 | 41.16 USD | $2.1M | SEC |